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Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, caused by progressive loss of
motor neurons. Changes are widespread in the subcortical white matter in ALS. Diffusion tensor imaging (DTI)
detects pathological changes in white matter fibres in vivo, based on alterations in the degree (diffusivity, ADC) and
directedness (fractional anisotropy, FA) of proton movement.
Methods: 24 patients with ALS and 24 age-matched controls received 1.5T DTI. FA and ADC were analyzed using
statistical parametric mapping. In 15 of the 24 ALS patients, a second DTI was obtained after 6 months.
Results: Decreased FA in the corticospinal tract (CST) and frontal areas confirm existing results. With a direct
comparison of baseline and follow-up dataset, the progression of upper motor neuron degeneration, reflected in
FA decrease, could be captured along the CST and in frontal areas. The involvement of cerebellum in the
pathology of ALS, as suspected from functional MRI studies, could be confirmed by a reduced FA (culmen, declive).
These structural changes correlated well with disease duration, ALSFRS-R, and physical and executive functions.
Conclusion: DTI detects changes that are regarded as prominent features of ALS and thus, shows promise in its
function as a biomarker. Using the technique herein, we could demonstrate DTI changes at follow-up which
correlated well with clinical progression.
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Amyotrophic lateral sclerosis (ALS) is a neurodegenera-
tive disorder characterized by progressive failure of
upper and lower motor neurons. In the ALS brain, de-
generation of fibres is widespread in the subcortical
white matter with surrounding astrogliosis. Degener-
ation commonly extends into the corticospinal tract
(CST), the central part of the corpus callosum and in
frontal areas as well as in long projection fibres as seen
in post-mortem tissue [1,2]. Previous studies have
demonstrated white matter changes in ALS using diffu-
sion tensor imaging (DTI), a technique that detects
alterations in both degree (diffusivity, ADC) and direct-
edness (fractional anisotropy, FA) of proton movement
reflecting changes in microstructural tissue and fibre or-
ganisation [3]. In ALS, DTI revealed a variable, but* Correspondence: tino.prell@med.uni-jena.de
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reproduction in any medium, provided the orwidespread pattern of white matter abnormalities which
were most prominent along the CST and the subcentral
white matter, and which extended into frontal regions
[4-9].
Symptoms indicating involvment of lower motor neu-
rons such as atrophic paresis may sometimes obscure
signs of upper motor neuron failure leading to a delay in
diagnosis and treatmentof ALS. Therefore, a biomarker
for diagnostic, prognostic, and monitoring purposes is
needed. Here, DTI shows promise as a potential bio-
marker, however, longitudinal studies are required to
further clarify the time course and distribution of chan-
gesdetected by this technique. By customizing scripting
in the Statistical Parametric Mapping software (SPM,
http://www.fil.ion.ucl.ac.uk/spm) we aimed to analyze
DTI datasets from 24 ALS patients, without having to
make a priori assumptions about localization of pathology.
To obtain longitudinal data on progress of microstructural
changes in ALS, a second examination was undertaken in
a subset of 15 patients at 6 months.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
We studied DTI image sets of 24 patients (T0) with
sporadic ALS and of 24 healthy age-matched controls.
In a subset of 15 of the 24 ALS patients (Follow-up), a
second examination was performed 6 months later. In
the 24 ALS patients, the mean (± S.D.) duration since
onset of dysarthria or weakness (termed disease dur-
ation) at MRI was 25.6 (± 27,8) months, the mean age
was 62.4 ± 10.5 (range 32.7–75.9) years, and the mean
revised ALS functional rating scale (ALSFRS-R) was
36.3 ±9 points. The female to male ratio was 1:1. 9
patients had a bulbar onset and 15 patients had, limb onset
of weakness. All patients were being treated with riluzole
and none were taking psychoactive drugs. Significant
frontal or cognitive dysfunctions were ruled out by
means of the Mini Mental State Examination (MMSE)
and the Frontal Assessment Battery test (FAB). In
addition, the 36-item Short Form Health Survey (SF36)Table 1 Characteristics of ALS patients
# Age Sex Onset El escorial Disease duration
mth
1* 67.9 f b p 3
2 72.5 f b p 6
3* 58.1 f b p 4
4* 72.0 m l p 31
5 75,9 m l p 15
6* 64,8 m l d 33
7 64,4 m l p 32
8* 32,7 m l d 19
9* 44,3 f l d 32
10* 64,5 f l s 3
11* 69,3 m b d 16
12* 70 f l s 37
13 68,6 f b p 7
14* 67,5 m l p 22
15* 49,7 m l s 10
16* 64,8 f l d 52
17 48,3 f l d 104
18* 71,3 m b p 8
19 60,2 m l p 18
20 54,9 d l p 13
21* 55,1 m b p 2
22* 64,1 f b d 13
23 74,4 m l p 107
24* 65,3 f b p 28
MW 61,5 25,6
SD 10,9 27,8
S.D. standard deviation, f/m female/male ratio, s suspected, p probable, d definite, l
who underwent follow-up.was completed by all patients enrolled and the physical
and executive subset was used for correlation analysis.
The 24 age-matched healthy controls (mean age 61.6 ±
9.2, range 36.6 – 71.9) had no history of a disease of the
central nervous system, their neurological examinations
were normal, and MRI T1 and T2 images revealed no
pathological findings. Finally, clinical diagnosis of ALS
was made according to the revised El-Escorial criteria.
Disease characteristics of patients enrolled in the study
are summarized in Table 1 [10]. All subjects gave written
informed consent to participate in the study, which was
approved by the local ethics committee.
Data acquisition
Images were acquired on a neuro-optimized 1.5-T GE
Signa Horizon LX (General Electric Company, Milwaukee,
WI, USA) using a 3-dimensional T1-weighted spoiled gra-
dient recalled echo (SPGR) sequence generating 124
contiguous sagittal slices (RT 24ms; TE 8ms; flip angleMMST FAB ALSFRS-R SF36 physic
0 6 0 6 0 6 0 6
30 17 45 45 100 100
30 30 17 18 44 100
29 28 16 18 46 43 25 20
30 29 17 17 39 32 35 35
29 12 25 5
29 28 15 12 32 27 0 0
30 16 43 20
30 30 18 18 30 27 0 0
29 no 18 no 18 18 0 0
28 27 15 9 45 35 10 5
30 29 14 16 33 32 0 0
27 30 15 18 35 31 10 10
21 12 47 100
29 28 18 18 45 45 95 95
30 17 47 60 0
30 30 18 18 37 37 0 0
no no no no 21 21 0
27 15 40 35 15
29 30 15 18 39 39 25
29 18 27 0
29 16 45 85 0
30 30 15 15 34 25 45 30
30 30 17 17 32 32 30
29 18 21 0 15
28,9 29,2 16,0 16,3 36,3 32,6 32,5 20,3
1,9 1,1 1,8 2,8 9,0 8,3 37,2 32,2
limb onset, b bulbar onset, T0 (month 0), 6 follow-up (month 6), * patients,
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lution 0.97 × 0.97 × 1.5 mm [3]). DTI was performed
using echoplanar imaging (EPI) (39 contiguous slices,
3 mm thickness, 2 × 2 mm in plane resolution, 24 direc-
tions, b=1000, total scanning time 25 min). During scan-
ning, all participants were placed comfortably and their
heads were fixated within the headcoil using special
cushions. All subjects received additional T2-weighted
images to exclude cerebrovascular disease.Pre-processing
Data were processed on a standard IBM-compatible PC
using SPM2 statistical parametric mapping software
(Welcome Department of Cognitive Neurology, London)
in the analysis environment MATLAB (version 6.1; the
Math Works Inc, Natick, Mass). Images were reoriented
into oblique axial slices aligned parallel to the anterior-
posterior commissural axis with the origin set to the an-
terior commissure.
After calculatingthe FA and ADC maps, images were
pre-processed and analyzed by statistical parametric
mapping (SPM2) using an approach adopted from
voxel-based morphometry as described herein by our
group [11]. This included an optimized normalisation
procedure, together with an automated exclusion of
skull and CSF signal values and smoothing (6-mm
FWHM). All EPI scans were normalized to the EPI-
template provided by SPM and further used to create
a site-specific EPI template appropriate to the popula-
tion sample and with scanner specific image contrast.
This site-specifc template was used again for normal-
isation and brain extraction for the individual images
in the group studied, which resulted in optimal
normalization and cleaning parameters for use with
the FA and ADC images.Statistical analysis
Processed images of each tissue class were analyzed in
the framework of the general linear model. ANCOVA
was applied to compare the groups of patients and
healthy controls (p < 0.05, corrected for the entire vol-
ume). Additionally, regression analyses with clinical
measures were explored for ALS patients using the
SPM2 model 'single subjects: covariates only'. In ac-
cordance with our anatomical a priori hypothesis
regarding white matter changes in ALS along the CST,
the statistical threshold was set at p < 0.001, corrected.
For regions where changes could be expected in the
follow-up (CST) [11,12], a small volume correction
(SVC) was undertaken and the family-wise-error
(FWE)-method (P < 0,05) for multiple comparisons
was used.Results
Clinical characterization
A total of 24 patients with sporadic ALS and the same
number of age- and gender-matched healthy controls
underwent MRI (T0) . In addition, DTI was performed
in 15 patients with ALS after six months (follow-up).
Based on MMST and FAB, no significant cognitive or
executive impairment was observed in the T0 (MMST
28.8 ± 1.57, FAB 16.04 ± 1.80) and in the follow-up
group (MMST 29.2 ± 1.07, FAB 16.31 ± 2.81). Three
patients switched from possible to probable laboratory-
supported ALS according to the revised El Escorial cri-
teria. In the follow-up group, theALSFRS-R and the
physical functioning SF36 subscore decreased from 35.4
(± 8.4) to 32,6 (± 8.3) and from 25,0 (± 33,0) to 20,7
(± 33,3) points, respectively after 6 months. Both reduc-
tions were not significant. Clinical characteristics of
patients are summarized in Table 1.
Whole-brain group differences in FA and ADC at T0
In the motor system, the FA in the ALS patient group
(n=24) was reduced within the precentral gyrus, in the
supplementary motor cortex, as well as in the CST at
the level of corona radiata, pons, and crus cerebri com-
pared to healthy controls. Further, FA was reduced in
the corpus callosum, the parahippocampal gyrus and in
frontal areas (Table 2).
Diffusivity was enhanced in the motor system (precentral
gyrus, premotor area, CST at the level of corona radiate,
pons), the postcentral gyrus, and in frontal and temporal
areas (Table 2). Enhanced diffusivity in the pons was ros-
trally located to pontine FA decrease.
Whole-brain group differences in FA and ADC at follow-up
According to T0 MRI in ALS patients (n=15) after 6
months, the FA was reduced in the CST (corona radi-
ate), the pons, the corpus callosum, and the parahippo-
campal gyrus. Additionally , FA was found decreased in
frontal areas (gyrus frontalis medialis), insula, in the lim-
bic system (amygdale), and in the thalamus at this time
point (Table 2, Figure 1).
In the follow-up group, the diffusivity was again
enhanced in the motor system (right precentral gyrus,
and in the CST at the level of corona radiate, internal
capsula). After SVC, there was a decrease in FA
bilaterally in the WM of precentral gyrus, along the CST
(corona radiate), and in the limbic system (fusiform
gyrus, uncus) (Table 2, Figure 1). After 6 months, micro-
structural changes had progressed along the descending
fibres and into the internal capsule.
Comparison of T0 to follow-up
Results of the 15 ALS patients, who had undergone
follow-up DTI analysis were compared to their T0 data
Table 2 Results of group comparisons of ALS patients versus controls
Side Cluster size x y z T p
T0 FA all ALS patients (n=24) < controls
Corpus Callosum l 7954 -10 -14 29 6.03 0.002
Corpus Callosum l -1 -16 25 5.35 0.003
Corpus Callosum r 11 -16 29 5.29 0.003
Brainstem, Pons, CST l 1589 -8 -27 -34 5.82 0.002
Brainstem, Pons, CST r 9 -26 -36 4.54 0.007
Brainstem, Pons, CST r 10 -22 -24 3.88 0.027
Precentral Gyrus, WM r 2386 14 -21 58 5.69 0.002
subgyral, WM, Corona Radiata r 27 -38 50 4.02 0.021
Medial Frontal Gyrus, WM, below BA 6 l 743 -12 -13 70 5.03 0.003
Precentral Gyrus, WM r 290 48 4 8 4.59 0.007
Corona Radiata, Medial Frontal Gyrus, below BA 6 l 687 -35 -12 48 4.37 0.01
Precentral Gyrus, WM l -39 -19 48 4.18 0.015
subgyral, WM, below Gyrus postcentralis l 201 -10 -37 61 4.35 0.011
Precentral Gyrus, subgyral, WM, Corona Radiata l 343 -42 -15 23 4.34 0.011
Precentral Gyrus, WM l 942 -28 -24 55 4.26 0.013
Frontal Lobe, subgyral, WM, Corona radiata l -17 -24 55 3.62 0.042
Frontal Lobe, subgyral, WM, Corona radiata r 345 33 -8 38 3.87 0.028
Frontal Lobe, Precentral Gyrus, WM, Corona radiata l 309 -39 -6 35 3.86 0.028
Frontal Lobe, Precentral Gyrus, BA 6 l -46 1 40 3.82 0.03
Limbic Lobe, Parahippocampal Gyrus, WM l 218 -20 -48 -11 3.80 0.032
T0 ADC all ALS patients (n =24) > controls
Precentral Gyrus, WM l 5108 -9 -25 67 5.99 0.02
Precentral Gyrus, subgyral, WM, below BA 6 l -28 -16 65 5.5 0.02
Frontal Lobe, subgyral, WM, Corona radiata l -28 -25 50 5.33 0.02
Precentral Gyrus, subgyral, WM r 5537 21 -16 65 5.56 0.02
Precentral Gyrus, WM r 11 -23 67 5.22 0.02
Frontal Lobe, subgyral, WM, Postcentral Gyrus r 15 -34 61 4.31 0.031
Brainstem, Pons r 3243 6 -22 -28 5.13 0.02
Brainstem, Pons l -4 -23 -28 4.21 0.034
Limbic Lobe, Parahippocampal Gyrus, WM r 26 -14 -14 3.98 0.041
Temporal Lobe, Superior Temporal Gyrus, GM l 547 -62 -12 -1 4.90 0.02
Parietal Lobe, Superior Parietal Lobule, subgyral, BA 7 r 754 21 -50 65 4.73 0.022
Precentral Gyrus, WM r 336 47 -2 31 4.55 0.025
Postcentral Gyrus, subgyral, WM l 645 -18 -32 71 4.22 0.034
Postcentral Gyrus, subgyral, WM l -27 -31 67 4.02 0.04
Frontal Lobe, Superior Frontal Gyrus, GM, BA 9 l 467 -22 42 39 4.15 0.036
Frontal Lobe, subgyral, WM l -25 39 29 3.78 0.046
Temporal Lobe, subgyral, WM l 409 -32 9 -35 4.11 0.037
Frontal Lobe, Superior Frontal Gyrus, WM r 269 5 20 53 4.02 0.04
Frontal Lobe, Medial Frontal Gyrus, GM, BA 8 l 383 -6 27 53 4.02 0.04
Limbic Lobe, Uncus, WM r 827 22 -3 -36 3.95 0.041
Limbic Lobe r 22 -8 -43 3.68 0.049
Frontal Lobe, Precentral Gyrus, subgyral, WM l 231 -51 -3 23 3.91 0.042
Sub-lobar, Insula, WM l 208 -40 -17 19 3.89 0.043
Frontal Lobe, Superior Frontal Gyrus, GM l 233 -22 10 57 3.88 0.043
Frontal Lobe, Middle Frontal Gyrus, GM, BA 8 l 217 -23 20 50 3.87 0.043
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Table 2 Results of group comparisons of ALS patients versus controls (Continued)
Frontal Lobe, Middle Frontal Gyrus, GM, BA 10 r 365 27 53 26 3.81 0.045
Frontal Lobe, Superior Frontal Gyrus, GM, BA 9 r 24 45 39 3.71 0.048
Follow-up FA all ALS patients (n =15) < controls
Precentral Gyrus, subgyral, WM, Corona radiata r 293 48 4 6 6.26 0.017
Corpus Callosum l 3260 -8 -18 28 5.70 0.017
Corpus Callosum r 11 -17 28 4.8 0.026
Left Brainstem, Pons l 218 -6 -28 -38 5.02 0.02
Limbic Lobe, Parahippocampal Gyrus, WM l 1004 -22 -42 -10 4.89 0.023
Temporal Lobe, Fusiform Gyrus, GM, BA 37 l -27 -37 -16 4.26 0.04
Sub-lobar, Thalamus, GM, Pulvinar l 217 -13 -33 1 4.51 0.033
Frontal Lobe, Medial Frontal Gyrus, WM, Corona radiata r 696 13 -26 58 4.44 0.035
Frontal Lobe, Medial Frontal Gyrus, WM, Corona radiata r 9 -27 69 4.28 0.04
parahippocampal Amygdala r 206 29 -30 -26 4.36 0.037
Limbic Lobe, Parahippocampal Gyrus, GM, BA 34 r 204 17 -7 -19 4.20 0.043
Follow-up ADC all ALS patients (n =15) > controls
Precentral Gyrus, WM r 3258 24 -20 63 6.18 0.036
Precentral Gyrus, subgyral, WM r 12 -21 62 5.01 0.001*
Precentral Gyrus, subgyral, WM, Corona radiata r 18 -20 43 4.1 0.013*
Sub-lobar, Extra-Nuclear, WM, Internal capsule, Crus post. r 379 18 -13 -1 4.32 0.008*
Sub-lobar, Extra-Nuclear, WM, Internal capsule, Crus post. l 1234 -18 -13 -2 4.28 0.009*
Sub-lobar, Extra-Nuclear, WM, Internal capsule, Crus post. l -19 -12 6 4.13 0.012*
Precentral Gyrus, WM l 351 -9 -25 65 4.27 0.009*
Precentral Gyrus, subgyral, WM, Corona radiata l 1148 -37 -11 43 4.16 0.011*
Precentral Gyrus, subgyral, WM, Corona radiata l -28 -25 50 4.16 0.012*
Precentral Gyrus, subgyral, WM, Corona radiata l -25 -22 42 4.06 0.012*
subgyral, WM, Corona radiata, below BA 6 l 241 -13 -14 59 4.08 0.014*
Ordered by descending T-values. R=right; L=left, * SVC 10mm (FWE).
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reduced at follow-up in the precentral gyrus, CST (at
the mesencephal level), in the cerebellum (culmen,
declive), the temporal and parietal lobe. Diffusivity was
significantly enhanced after 6 months both in the in-
ternal and external capsule (Table 3, Figure 2).Correlation with clinical scores at T0
Disease duration negatively correlated with FA in pre-
central gyrus, CST (corona radiate, internal capsule)
and the cerebellum, which means that in these areas
FA decreases with time course of ALS. Changes in dif-
fusivity did not correlate with disease duration. The
ALSFRS-R positively correlated with FA in the CST, and
the cerebellum. The ALSFRS-R did not correlate with
diffusivity. Physical and executive function, reflected in
SF36 subscore, positively correlated with FA in the cere-
bellum, but did not correlate with changes in diffusivity.
This means that worsening ALS, indicated by a decrease
of ALSFRS-R or SF36 subscore, is reflected as FA de-
crease in the CST and cerebellum (Table 4).Correlation with clinical scores at follow-up
After 6 months, the DTI data were correlated with clin-
ical parameters. With respect to SVC, the FA negatively
correlated with disease duration along the CST in the in-
ternal and external capsule. However, the decrease of FA
was higher on the left side. Again diffusivity changes did
not correlate with disease duration. ALSFRS-R positively
correlated with FA in the precentral gyrus, the CST (cor-
ona radiate), the WM of right middle frontal gyrus and
supplementary motor cortex. ALSFRS-R did not correl-
ate with diffusivity changes. Physical and executive func-
tion (SF36 subscore) positively correlated with FA in the
CST at brain stem level and negatively with diffusivity in
the cerebellum (anterior lobe, dentatus, fastigium) and
parahippocampal gyrus (Table 4).Discussion
Involvement of the white matter in ALS is increasingly
being recognized and extensive white matter abnormal-
ities can be found in the region of the central sulcus and
the CST, extending across the corpus callosum and into
Figure 1 Group comparisons of ALS patients versus controls. A results are superimposed on the mean of all subjects of spatially normalized
anisotropy images. Voxels with a significant decrease in FA in the patients versus controls are found in the precentral gyrus, the CST and pons
(p < 0,001 uncorrected). ADC results are superimposed on the mean of all subjects of spatially normalized anisotropy images. Voxels with a significant
increase in ADC in the patients versus controls are found in the precentral gyrus, CST, pons, frontal ares and limbic system (p < 0,001 uncorrected).
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the myelin coating of axons are important determinants
for anisotropic diffusion in neural tissues [13] and there-
fore, a reduced FA along the CST in ALS patients
reflects axonal fibre degeneration and myelin pallor [1].
In the present study, microstructural changes in the
brains of ALS patients could be demonstrated asdecreased FA and increased diffusivity mainly in the
pyramidal motor system, frontotemporal areas, limbic
system, and the cerebellum. Comparison of the
follow-up group with healthy probands revealed a pro-
gressive decrease in FA and diffusivity increase along
the CST after 6 months. Increasing fiber tract path-
ology during disease course could be verified by direct
Table 3 Results of direct comparisons of ALS patients and correlation analysis
Side Cluster size x y z T p
Paired t-test FA T0 / Follow-up
Temporal Lobe, Superior Temporal Gyrus, GM, BA 39 l 879 -49 -62 28 7.5 0.001*
Temporal Lobe, Superior Temporal Gyrus, GM, BA 39 l -56 -64 16 4.82 0.033*
Parietal Lobe, Supramarginal Gyrus, GM, BA 40 l -58 -61 30 4.19 0.075*
Cerebellum, Posterior Lobe, Declive r 921 24 -59 -25 6.88 0.002*
Cerebellum, Anterior Lobe, Culmen r 34 -52 -21 4.25 0.07*
Precentral Gyrus, WM r 743 44 -9 41 6.67 0.003*
Precentral Gyrus, WM r 53 -6 43 5.56 0.012*
Superior Temporal Gyrus, WM r 2014 65 -39 10 6.36 0.004*
Superior Temporal Gyrus, GM, BA 22 r 61 -59 16 5.95 0.008*
Superior Temporal Gyrus, GM, BA 22 r 65 -48 20 5.12 0.022*
Parietal Lobe, Precuneus, WM r 582 35 -74 39 6.21 0.005*
Brainstem, Midbrain, CST r 270 16 -16 -17 5.89 0.008*
Temporal Lobe r 756 44 8 -42 5.72 0.01*
Superior Frontal Gyrus, WM r 221 35 39 35 5.27 0.018*
Middle Frontal Gyrus, subgyral, WM r 29 34 31 4.76 0.035*
Superior Frontal Gyrus, GM, BA 11 r 487 28 45 -18 4.90 0.03*
Temporal Lobe, Middle Temporal Gyrus, WM r 253 60 -7 -9 4.77 0.035*
Temporal Lobe, Superior Temporal Gyrus, WM r 57 -2 3 4.33 0.063*
Paired t-test ADC T0 / Follow-up
Extra-Nuclear, WM, External capsule l 2054 -28 2 -3 6.38 0.003*
Extra-Nuclear, WM, External capsule l -29 -15 11 6.16 0.004*
Extra-Nuclear, WM, External capsule l -25 -1 8 5.5 0.01*
Extra-Nuclear, WM, Internal capsule l 383 -19 8 3 5.94 0.005*
Ordered by descending T-values. R=right; L=left, * SVC 10mm (FWE).
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15 patients. Brain structure pathology correlated well
with disease duration, ALSFRS-R andthe SF-36 sub-
score for physical and executive function, predomin-
antly in the range of motor system, but interestingly
also in the cerebellum and the limbic system.Widespread DTI changes in motoric and extramotoric
systems in ALS
The decreased FA in the internal capsule and premotor
cortex is in accordance with several DTI studies in ALS
[4,6,8,9,14-23]. Microstructural alterations in frontal
areas are in line with bilateral frontal atrophy in VBM
[11,24-26], an increase of diffusivity in frontal regions
[21,27] and observed in post mortem brain tissues [1].
Since the corpus callosum connects orbitofrontal and
frontal cortices, its involvement in ALS is a consistent
feature [9,28] and together with the known DTI changes
in the hippocampal formations, cingulum, and frontal
white matter, may reflect cognitive impairment, which is
often recognized in patients with ALS [29,30]. However,
aside from ruling out clinical significant dementia bymeans of MMSE and FAB, we did not undertake
detailed neuropsychological testing.Involvement of cerebellum in ALS
The cerebellum has been little studied in ALS, probably
because of the lack of cerebellar signs in most patients.
However, evidence for the involvement of cerebellum
in ALS derives from early pathological [31,32] and
functional magnetic resonance imaging (fMRI) studies.
Besides the enhanced activity in sensorimotor network,
fMRI studies in ALS have demonstrated the recruitment
of additional areas, such as the cerebellum and basal
ganglia [33-37]. Hence, it is probable that functional
compensation in ALS relies on existing resources and
mechanisms and not on development of new synapses
or pathways [35]. Structural changes of cerebellum in
ALS could be demonstrated as regional white matter
alterations [26] and decreased grey matter volume [38]
in VBM and as increased diffusivity in the anterior
lobe of the cerebellum bilateral [21].
In the present study, the direct comparison after 6
months showed a reduced FA in the cerebellum (culmen,
Figure 2 Direct comparison between T0 and follow-up in ALS patients. Comparison of FA results between T0 and follow-up (n=15) with
paired t-test superimposed on the mean of all subjects of spatially normalized anisotropy images. FA is significantly reduced in the follow-up in
the precentral gyrus, CST (at the mesencephal level), in the cerebellum (culmen, declive), the temporal and parietal lobe (p < 0,001 uncorrected).
Comparison of ADC results between T0 and follow-up (n=15) with paired t-test superimposed on the mean of all subjects of spatially normalized
anisotropy images. Diffusivity is significantly enhanced after 6 months in the internal and external capsule (p < 0,001 uncorrected).
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lated with disease duration, ALSFRS-R, physical and ex-
ecutive functions. Since, the cerebellum contributes to
coordination and improvement of motor performance
and is involved in motor learning [39], the abnormal con-
nectivity found between the supplementary motor cortex
and cerebellar areas is therefore not only of functional,
but also of a structural nature [35,37]. One couldhypothesise that as a consequence of limited resources in
the motor cortex, these cerebellar regions are activated
due to an enhanced modulatory response in ALS. How-
ever, this compensation is paralleled by a progressive
structural alteration of connectivity, finally leading to an
ineffective modulation. However, the exact clinical and
pathological relevance of these findings is not quite clear.
We speculate that the structural changes in the
Table 4 Correlations with clinical data
Side Cluster size x y z T p
T0 FA correlation with ALSFRS-R
Right Brainstem, Midbrain r 233 10 -24 -21 4.41 0.019*
Cerebellum, Posterior Lobe, Declive r 251 13 -58 -19 3.99 0.04*
T0 FA correlation with disease duration
Precentral Gyrus, WM, below BA 6 r 596 4 -27 70 4.93 0.007*
Precentral Gyrus, subgyral, WM, Corona radiata r 6 -30 61 4.52 0.014*
Sub-lobar, WM, CST, Internal capsule l 867 -31 -26 17 4.58 0.013*
Sub-lobar, WM, CST, Internal capsule l -30 -18 15 4.47 0.017*
Cerebellum, Anterior Lobe, Culmen r 317 12 -56 -15 4.56 0.014*
Sub-lobar, WM, CST, Corona radiata l 202 -13 -29 51 4.37 0.02*
T0 FA correlation with SF36
Cerebellum, Anterior Lobe, Culmen r 715 19 -43 -27 5.24 0.004*
Cerebellum, Anterior Lobe r 10 -42 -33 4.4 0.019*
Cerebellum, Anterior Lobe l 561 -10 -41 -33 4.84 0.008*
Cerebellum, Anterior Lobe, Culmen l -16 -42 -27 4.22 0.027*
Follow-up FA correlation with ALSFRS-R
Precentral Gyrus, subgyral, WM, BA 6 r 469 50 2 38 6.35 0.006*
Precentral Gyrus, subgyral, WM, BA 6 r 46 -5 46 6.11 0.008*
Frontal Lobe, Middle Frontal Gyrus, WM r 233 33 13 50 5.99 0.01*
Precentral Gyrus, WM, Corona radiata r 417 29 -15 56 5.87 0.011*
Precentral Gyrus, WM, Corona radiata l 219 -16 -12 59 5.01 0.014*
Follow-up FA correlation with disease duration
Capsula Inerna, Crus post., CST l 1722 -24 -19 2 6.87 0.003*
Sub-lobar, WM, Capsula Inerna, Crus post., CST l -28 -25 14 5.7
Internal capsule, Crus post., CST r 408 24 -16 -4 5.69 0.014*
Internal capsule, Crus post., CST r 32 -17 -5 4.12
External capsule r 431 31 -12 10 5.61 0.015*
Follow-up FA correlation with SF36
Brainstem, Pons, CST l 387 -11 -32 -34 5.37 0.02*
Ordered by descending T-values. R=right; L=left, * SVC 10mm (FWE).
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pensatory mechanism for the progressive loss of motor
function. Further studies should evaluate cerebellar signs
in more detail and undertake a comparison of cerebellar
involvment in familal and sporadic ALS. Nevertheless
with regard to studying cerebellar structures using DTI,
several methodological limitations have to be taken into
account such as the low resolution after normalization
and the incomplete mapping of cerebellum. Moreover,
measurement of radial and axial diffusivities would
provide more specific information relating to diffusion
tensor.
Follow-up
The few existing longitudinal DTI studies have captured
the progression of upper motor neurone degeneration in
ALS by demonstrating decreasing FA over time along
the CST [40-42]. Fibertracking of the mean CST showeda reduction of FA in a follow-up examination of ALS
patients, indicating that degeneration of the CST appears
to worsen over time [7]. In another six-month follow-up
study, ALS patients showed DTI abnormalities that
extended mainly into the bilateral frontal lobes [43].
Accordingly in our study, the disease progression was
reflected in a progressive FA decrease along the CST,
which correlated with disease duration and the decrease
of ALSFRS-R. However, it is important to note that
ALSFRS-R is a composite score of upper and lower
motor neuron components, whereas FA changes along
the CST may reflect more upon upper motor neuron
degeneration. For further studies, it would be useful to
correlate FA changes with ALSFRS-R subscores.
Furthermore, it remains unclear as to why regions
with FA decrease (corona radiate, corpus callosum, brain
stem) after 6 months appear smaller. In addition to
method-based explanations, a possible interaction with
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also a plausible reason that could be discussed. Finally,
we detected at 6 months follow-up that increase in diffu-
sivity progressed in a caudal (CST) and frontal direction
(premotor cortex). The direct comparison of follow-up
patients with T0 data supports the observed progression
of FA changes and revealed microstructural changes in
regions which were not detected when comparing ALS
patients with normal controls in the group comparison.
Conclusions
In summary, our study provides further evidence for the
well known structural changes in the CST and in frontal
areas in the brains of ALS. Further, we demonstrate the
involvement of cerebellum as a feature of disturbed con-
nectivity in ALS, supported by the correlation analysis
with clinical datasets. It seems that the extent of ALS-
related DTI abnormalities is greater than those identified
by VBM analysis [9,21], and that DTI can serve as stable
biomarker in ALS [44].
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